Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Adagio Medical Holdings (ADGM) EBT (2023 - 2026)

Adagio Medical Holdings has reported EBT over the past 4 years, most recently at -$5.9 million for Q1 2026.

  • Quarterly EBT rose 25.64% to -$5.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$22.2 million through Mar 2026, up 24.91% year-over-year, with the annual reading at -$24.3 million for FY2025, 61.5% up from the prior year.
  • EBT was -$5.9 million for Q1 2026 at Adagio Medical Holdings, down from -$4.6 million in the prior quarter.
  • Over five years, EBT peaked at -$4.6 million in Q4 2025 and troughed at -$9.6 million in Q1 2024.
  • The 4-year median for EBT is -$6.1 million (2023), against an average of -$6.7 million.
  • Year-over-year, EBT skyrocketed 50.92% in 2024 and then crashed 36.15% in 2025.
  • A 4-year view of EBT shows it stood at -$5.9 million in 2023, then increased by 20.56% to -$4.7 million in 2024, then grew by 1.77% to -$4.6 million in 2025, then decreased by 27.33% to -$5.9 million in 2026.
  • Per Business Quant, the three most recent readings for ADGM's EBT are -$5.9 million (Q1 2026), -$4.6 million (Q4 2025), and -$6.4 million (Q3 2025).